BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 74239)

  • 1. Pemphigus-like antibodies in bullous pemphigoid.
    Heine KG; Kumar A; Jordon RE
    Arch Dermatol; 1977 Dec; 113(12):1693-5. PubMed ID: 74239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
    Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
    Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
    Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
    J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study on 70 human embryos concerning the epidermal binding of pemphigus and pemphigoid antibodies.
    Varelzidis A; Tosca A; Coumantakis E; Nicolis G; Hatzis J; Papavasiliou S; Stratigos J
    Acta Derm Venereol; 1980; 60(2):129-33. PubMed ID: 6155018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunology of bullous diseases (pemphigus vulgaris and bullous pemphigus)].
    Diaz-Pérez JL
    Med Cutan Ibero Lat Am; 1976; 4(4):271-80. PubMed ID: 798081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus and pemphigoid: dermatologic examples of type II immune reactivity.
    Sams WM
    Ann Allergy; 1976 Oct; 37(4):255-63. PubMed ID: 791025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of antibody determination in the diagnosis of pemphigus and pemphigoid in the oral cavity using the indirect immunofluorescence method].
    Drízhal I; Nozicka Z; Rozsívalová V
    Cesk Stomatol; 1981 Mar; 81(2):94-9. PubMed ID: 7013995
    [No Abstract]   [Full Text] [Related]  

  • 8. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
    Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
    Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stimulation of autoantibody formation in pemphigoid due to proteolytic enzymes?].
    Remy W; Bockendahl H; Stüttgen G
    Hautarzt; 1976 Jul; 27(7):344-6. PubMed ID: 783086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized pemphigoid simulating dyshidrosiform dermatitis.
    Levine N; Freilich A; Barland P
    Arch Dermatol; 1979 Mar; 115(3):320-1. PubMed ID: 373634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin].
    Muramatsu T; Sakamoto K; Ikeda S
    Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic aspects of bullous diseases.
    Safai B
    Pahlavi Med J; 1977 Jan; 8(1):106-32. PubMed ID: 319409
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunofluorescence studies of pemphigus and pemphigoid in Singapore.
    Tan T; Ratnam KV
    Ann Acad Med Singap; 1983 Jan; 12(1):13-8. PubMed ID: 6344738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillamine-induced bullous pemphigoid with pemphigus-like antibodies.
    Rasmussen HB; Jepsen LV; Brandrup F
    J Cutan Pathol; 1989 Jun; 16(3):154-7. PubMed ID: 2671069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cicatricial pemphigoid of Brunsting-Perry. Immunofluorescent studies.
    Michel B; Bean SF; Chorzelski T; Fedele CF
    Arch Dermatol; 1977 Oct; 113(10):1403-5. PubMed ID: 334084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent follow-up studies in patients with bullous dermatoses.
    Remy W; Bockendahl H; Stüttgen G
    Acta Derm Venereol; 1975; 55(2):117-20. PubMed ID: 48314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
    Sugi T; Hashimoto T; Hibi T; Nishikawa T
    J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous dermatosis and myeloma. Monoclonal anticytoplasmic antibody activity.
    Vincendeau P; Claudy A; Thivolet J; Tessier R; Texier L
    Arch Dermatol; 1980 Jun; 116(6):681-2. PubMed ID: 6990873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.